News | October 26, 2011

Higher Levels of Testosterone in Elderly Men May Prevent Cardiovascular Events

October 26, 2011 – Older men whose bodies produce higher levels of testosterone may be protected against heart attacks and strokes, new medical research suggests.

According to the study of 2,400 Swedish men in their 70s and 80s, published in the Journal of the American College of Cardiology, high-yet-normal testosterone level in elderly men may lower the risk of cardiovascular disease by helping to increase lean body mass and decrease body fat and cholesterol, while also helping the body to control blood-sugar levels.

As summarized by Asa Tivesten, M.D., a well-known testosterone researcher and leader of the study at Sahlgrenska University in Goteborg, Sweden:

"...Elderly men with high testosterone levels are relatively protected against cardiovascular events..."

Further, the study shows that lower testosterone is a marker for higher cardiovascular risk, according to Tivesten.

The research findings indicate that elderly men with the highest testosterone levels were less likely to suffer heart attacks or strokes than men whose testosterone levels were the lowest.

However, this study does not prove that testosterone by itself leads to improved outcomes, since medical researchers already know that many different health conditions can lower the body's testosterone level, including obesity, blood pressure, diabetes, or prior history of heart disease or stroke.

As revealed by the data in the study, of the approximately 600 men with testosterone levels in the bottom quarter of the study group, 21 percent suffered a cardiovascular health problem such as a heart attack, serious chest pain or stroke within the five-year period of the study. In contrast, of the approximately 600 men with the highest testosterone levels, only about 16 percent experienced such problems.

The researchers also found that after adjusting the numbers to account for overall health conditions, those men with high testosterone still benefited from a 30 percent lower risk of cardiac disease and stroke.

It may be premature to suggest testosterone replacement alone as a treatment or preventive measure against cardiac risks. The results from this study do not mean that testosterone is responsible for improving cardiac health by itself, since it is possible that other factors may be involved, according to Joann E. Manson, M.D., professor of medicine at Harvard Medical School, who said, "Low testosterone may be a marker of other health conditions that put men at higher risk of cardiovascular disease."

She indicated that evidence is needed from more clinical trials, in order to determine whether testosterone replacement reduces cardiovascular risks in older men, or whether it ultimately increases lifespan.

There is reason to be cautious. In the 1980s, a large clinical trial found that then-current hormone replacement therapy (HRT) in women often led to worse outcomes, greatly limiting the value of such therapies. Medical professionals are concerned about the potential for similar issues in men, since hormone therapy may lead to blood clots, liver cirrhosis, and other problems.

Doctors are hopeful that these recent research findings will lead to significant advances in treatment and therapy for a range of ailments, as medical researchers continue to explore the role that testosterone plays in men's cardiovascular health.

For more information: http://content.onlinejacc.org/cgi/content/abstract/58/16/1674

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Overlay Init